McGlone Suttner Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-786
Closed -$226K 170
2024
Q2
$226K Buy
+786
New +$231K 0.05% 146
2024
Q1
Sell
-786
Closed -$226K 195
2023
Q4
$226K Sell
786
-18
-2% -$4.9K 0.04% 146
2023
Q3
$216K Buy
+804
New +$201K 0.05% 131
2023
Q1
Sell
-1,120
Closed -$294K 141
2022
Q4
$294K Buy
+1,120
New +$300K 0.09% 98

Other funds holding AMGN

McGlone Suttner Wealth Management's AMGN Position: Q3 2024 in Review

McGlone Suttner Wealth Management sold out of Amgen (AMGN) in Q3 2024, closing a stake of 786 shares — an estimated $226K sold.

McGlone Suttner Wealth Management first reported a position in AMGN in Q4 2022 and held it in 4 quarters. The position peaked at $294K in Q4 2022. 2,824 funds tracked by Wall St. Rank hold AMGN as of Q3 2024.

  • McGlone Suttner Wealth Management reported no remaining Amgen position as of Q3 2024 after selling out during the quarter.
  • McGlone Suttner Wealth Management sold 786 Amgen shares in Q3 2024, an estimated $226K.
  • McGlone Suttner Wealth Management first reported a position in Amgen in Q4 2022 and held it in 4 quarters.
  • McGlone Suttner Wealth Management's Amgen position peaked at $294K in Q4 2022.
  • 2,824 funds tracked by Wall St. Rank held Amgen as of Q3 2024.

Based on McGlone Suttner Wealth Management's 13F filing for Q3 2024, filed 10 Oct 2024.